This is the accessible text file for GAO report number GAO-10-610R 
entitled 'Centers for Disease Control and Prevention: An Appropriate 
Methodology Is Needed for Determining Administrative Costs 
Attributable to the Agency for Toxic Substances and Disease Registry' 
which was released on May 20, 2010. 

This text file was formatted by the U.S. Government Accountability 
Office (GAO) to be accessible to users with visual impairments, as 
part of a longer term project to improve GAO products' accessibility. 
Every attempt has been made to maintain the structural and data 
integrity of the original printed product. Accessibility features, 
such as text descriptions of tables, consecutively numbered footnotes 
placed at the end of the file, and the text of agency comment letters, 
are provided but may not exactly duplicate the presentation or format 
of the printed version. The portable document format (PDF) file is an 
exact electronic replica of the printed version. We welcome your 
feedback. Please E-mail your comments regarding the contents or 
accessibility features of this document to Webmaster@gao.gov. 

This is a work of the U.S. government and is not subject to copyright 
protection in the United States. It may be reproduced and distributed 
in its entirety without further permission from GAO. Because this work 
may contain copyrighted images or other material, permission from the 
copyright holder may be necessary if you wish to reproduce this 
material separately. 

GAO-10-610R: 

United States Government Accountability Office: 
Washington, DC 20548: 

May 19, 2010: 

The Honorable Dianne Feinstein: 
Chairman:
The Honorable Lamar Alexander: 
Ranking Member:
Subcommittee on Interior, Environment, and Related Agencies: 
Committee on Appropriations:
United States Senate: 

The Honorable James P. Moran: 
Chairman:
The Honorable Michael K. Simpson: 
Ranking Member:
Subcommittee on Interior, Environment, and Related Agencies: 
Committee on Appropriations:
House of Representatives: 

Subject: Centers for Disease Control and Prevention: An Appropriate 
Methodology Is Needed for Determining Administrative Costs 
Attributable to the Agency for Toxic Substances and Disease Registry: 

This letter formally transmits and summarizes an oral briefing we gave 
on April 12, 2010, in response to House of Representatives Explanatory 
Statement, 155 Cong. Rec. H2113 (daily ed., Feb. 23, 2009), 
accompanying the Omnibus Appropriations Act, 2009 (Pub. L. No. 111-8, 
123 Stat. 524) (2009). A copy of our briefing slides is enclosed. GAO 
was directed to review the indirect costs the Agency for Toxic 
Substances and Disease Registry (ATSDR) paid the Centers for Disease 
Control and Prevention (CDC). Specifically, our objectives were to (1) 
describe CDC's methodology for determining and allocating indirect 
costs to bill ATSDR for administrative services and (2) determine if 
the methodology CDC uses to bill ATSDR appropriately considers 
relevant laws and guidance. To address these objectives, we: 

* identified and reviewed applicable sections of laws and guidance; 
[Footnote 1] 

* obtained and reviewed relevant documents, including the studies 
related to CDC's indirect cost methodology that was implemented in 
fiscal year 2002;[Footnote 2] 

* reviewed relevant reports from the Department of Health and Human 
Services Office of the Inspector General and financial statement 
auditors; 

* obtained and reviewed schedules and interagency agreements 
documenting the indirect costs charged to ATSDR for fiscal years 2002 
through 2010; and: 

* interviewed CDC and ATSDR officials and staff. 

We conducted this performance audit from August 2009 to April 2010, in 
accordance with generally accepted government auditing standards. 
Those standards require that we plan and perform the audit to obtain 
sufficient, appropriate evidence to provide a reasonable basis for our 
findings and conclusions based on our audit objectives. We believe 
that the evidence obtained provides a reasonable basis for our 
findings and conclusions based on our audit objectives. 

In summary, we found that CDC had charged ATSDR approximately $12.1 
million annually for indirect costs each year since 2004. This was the 
amount calculated for fiscal year 2004 using the methodology CDC 
implemented in fiscal year 2002. 

We also found that CDC's approach to determine indirect costs to 
charge ATSDR did not appropriately address relevant laws or 
guidance.Specifically, CDC had not calculated the actual costs of 
providing services to ATSDR as required under the Economy Act. Also, 
it had not updated its approach to use an appropriate methodology with 
current cost information and assumptions as called for by relevant 
guidance. Under the Economy Act, ATSDR must reimburse CDC for the 
"actual cost" of providing the services, which generally includes all 
direct and indirect (e.g., overhead) costs. Other relevant guidance 
for calculating indirect costs states that entities should (1) use and 
consistently follow costing methodologies or cost finding techniques 
most appropriate to the operating environment to accumulate and assign 
costs; (2) document managerial cost accounting activities, processes, 
and procedures; and (3) periodically evaluate indirect costing 
methods. Because CDC had not used an appropriate documented cost 
methodology, it is not possible to determine whether ATSDR may have 
been overcharged or undercharged for the administrative services 
provided by CDC. In April 2010, CDC awarded a task order for a new 
indirect cost study. The contractor is expected to provide CDC with a 
final report no later than 270 days following the award of the task 
order, and the task order requires that the new indirect cost 
methodology comply with relevant laws and guidance. See the enclosure 
for additional information on the results of our work. 

We made recommendations to the Director of CDC to assist the agency in 
providing a reasonable basis for indirect costs charged and to assist 
the Congress and agency officials in making decisions about allocating 
federal resources. 

In commenting on a draft of our briefing slides, officials at CDC and 
ATSDR agreed with our recommendations and provided technical comments 
that we incorporated as appropriate. 

We are sending copies of this report to the appropriate congressional 
committees, to the Director of CDC and the Administrator of ATSDR, and 
to other interested parties. This report will also be available at no 
charge on our Web site at [hyperlink http://www.gao.gov]. Should you 
or your staff have any questions concerning this report, please 
contact me at 202-512-9095 or dalykl@gao.gov. Contact points for our 
Offices of Congressional Relations and Public Affairs may be found on 
the last page of this report. Key contributors to this report were 
Sabrina Springfield, Assistant Director; Jehan Abdel-Gawad; F. Abe 
Dymond; Jean Mathew; Donell Ries; Ivy Wu; and J. Mark Yoder. 

Signed by: 

Kay L. Daly:
Director:
Financial Management and Assurance: 

Enclosure: 

[End of section] 

Centers for Disease Control and Prevention: 

An Appropriate Methodology Is Needed for Determining Administrative 
Costs Attributable to the Agency for Toxic Substances and Disease 
Registry: 

Briefing for the Subcommittees on Interior, Environment, and Related 
Agencies, Committees on Appropriations, United States Senate and House 
of Representatives: 

April 12, 2010: 

Overview: 
* Background; 
* Objectives; 
* Scope and Methodology; 
* Results; 
* Conclusions; 
* Recommendations for Executive Action; 
* Agency Comments and Our Evaluation; 
* GAO Contact and Staff Acknowledgments. 

Background: 

The Centers for Disease Control and Prevention (CDC) is one of the 
major operating components of the Department of Health and Human 
Services (HHS). Its mission is to promote health and quality of life 
by preventing and controlling disease, injury, and disability. CDC 
accomplishes its mission by working with states, communities, and 
other partners to monitor health, detect and investigate health 
problems, conduct research, implement prevention strategies, promote 
healthy behaviors, foster safe and healthful environments, and provide 
leadership and training. 

The Agency for Toxic Substances and Disease Registry (ATSDR), another 
component of HHS, was created by the passage of the Comprehensive 
Environmental Response, Compensation, and Liability Act of 1980, more 
commonly known as the Superfund law. The agency is charged with 
evaluating the human health effects of exposure to hazardous 
substances. 

CDC provides administrative services to its internal organizational 
units and to others, including ATSDR.[Footnote 3] These services 
include budget formulation, accounting, procurement, information-
technology services, human-resources management, facilities 
management, security services, and telecommunications. 

CDC charges a fee to ATSDR and others to recoup its costs for 
providing these services, which it considers indirect costs.[Footnote 
4] 

In the Explanatory Statement accompanying the Omnibus Appropriations 
Act, 2009, the committee directed GAO to review the indirect costs 
paid by ATSDR to CDC.[Footnote 5] 

In the related House report, it was noted that the amount charged by 
CDC to ATSDR has represented over 16 percent of ATSDR's annual budget 
authority. Also, the report noted that CDC announced plans to 
recommission a study to update the way it determines administrative 
costs. Furthermore, the committee directed that the results of the 
study be reported immediately for decision-making purposes on ATSDR's 
appropriation.[Footnote 6] 

[End of section] 

Objectives: 

Our objectives were to: 

* describe CDC's methodology for determining and allocating indirect 
costs to bill ATSDR for administrative services, and, 

* determine if the methodology CDC uses to bill ATSDR appropriately 
considers relevant laws and guidance. 

[End of section] 

Scope and Methodology: 

To address the objectives, we: 

* identified and reviewed applicable sections of laws and guidance to 
assess CDC's indirect cost methodology;[Footnote 7] 

* obtained and reviewed relevant documents, including CDC's indirect 
cost studies that related to the methodology implemented in fiscal 
year 2002, to gain an understanding of CDC's indirect cost methodology;
- We did not validate the fiscal year 2002 methodology or
the data, which were last updated in fiscal year 2004,
because CDC did not maintain related documentation;[Footnote 8] 

* reviewed relevant reports from the HHS Office of the Inspector 
General and financial auditors to identify any previously reported 
weaknesses in CDC's fiscal year 2002 indirect cost methodology; 
[Footnote 9] 

* obtained and reviewed schedules and interagency agreements 
documenting the indirect costs charged to ATSDR for fiscal years 2002 
through 2010 to determine trends; 

* interviewed CDC officials, including the Chief Financial Officer, 
the Director of the Financial Management Office (FMO), and the Deputy 
Budget Director within FMO, to obtain an understanding of the indirect 
cost methodology; and; 

* interviewed ATSDR and CDC staff responsible for monitoring the costs 
charged by CDC to obtain additional details about the methodology. 

We conducted this performance audit from August 2009 to April 2010, in 
accordance with generally accepted government auditing standards. 
Those standards require that we plan and perform the audit to obtain 
sufficient, appropriate evidence to provide a reasonable basis for our 
findings and conclusions based on our audit objectives. We believe 
that the evidence obtained provides a reasonable basis for our 
findings and conclusions based on our audit objectives. 

[End of section] 

Results: 

CDC Continues to Charge ATSDR for Administrative Services Based on a 
Calculation That Has Not Been Updated since Fiscal Year 2004: 

CDC's fiscal year 2002 methodology used various factors and 
assumptions to accumulate and allocate indirect costs to both internal 
and external entities and programs for which it provided 
administrative services. 

CDC officials stated that after fiscal year 2004 they ceased using the 
methodology to calculate indirect costs because they believed the 
methodology was no longer appropriate due to changes made to the 
organizational and budget structures and was not needed to allocate 
indirect costs for its internal management purposes. 

As a result, CDC has charged ATSDR approximately $12.1 million 
annually for indirect costs each year since 2004. This was the amount 
calculated for fiscal year 2004 using its methodology. 

CDC Does Not Use an Indirect Cost Methodology That Appropriately 
Addresses Relevant Laws and Guidance: 

The CDC approach used to determine indirect costs to charge ATSDR did 
not appropriately address relevant laws or guidance. Specifically, CDC 
had not calculated the actual costs of providing services to ATSDR 
under the Economy Act. Also, it had not updated its approach to use an 
appropriate methodology with current cost information and assumptions 
as called for by relevant guidance. 

Under the Economy Act, the requesting agency must reimburse the 
servicing agency for the "actual cost" of providing the services, 
which generally includes all direct and indirect (e.g., overhead) 
costs funded out of the performing agency's currently available 
appropriations that bear a significant relationship to providing the 
goods or services. When determining the reimbursable actual costs 
under the Economy Act, agencies should apply reasonable and 
appropriate methodologies that meet these minimum requirements. 
[Footnote 10] 

Other relevant guidance[Footnote 11] for calculating indirect costs 
states that entities should: 

* use and consistently follow costing methodologies that consider 
current cost information and assumptions or cost finding techniques 
most appropriate to the operating environment to accumulate and assign 
costs; 

* document managerial cost accounting activities, processes, and 
procedures; and; 

* periodically evaluate indirect costing methods because operations, 
program funding levels, and requirements change over time, and 
therefore long-standing methods, if unchanged, may result in an 
inappropriate allocation of costs. 

Based on its analysis of select changes in factors and assumptions 
used in the fiscal year 2002 methodology, ATSDR asked CDC to 
reevaluate the indirect cost it was scheduled to be charged for fiscal 
year 2009. 

CDC officials told us that ATSDR's analysis did not include or update 
all of the factors and assumptions used in the fiscal year 2002 
methodology. 

However, because CDC had not used an appropriate documented cost 
methodology, it is not possible to determine whether ATSDR may have 
been overcharged or undercharged for the administrative services 
provided by CDC.[Footnote 12] 

CDC officials told ATSDR that no adjustment would be made to the 
amount it charges ATSDR until a new indirect cost allocation 
methodology is developed and implemented. 

In December 2009, CDC issued a request for quotations to contractors 
for the development of a new indirect cost methodology. CDC awarded a 
task order dated April 6, 2010, for a new indirect cost study. The 
contractor is expected to provide CDC with initial recommendations for 
an indirect cost model no later than 120 days following the award of 
the task order and a final report no later than 270 days following the 
award of the task order. The task order requires that the new indirect 
cost methodology comply with relevant laws and guidance. 

[End of section] 

Conclusions: 

CDC has continued to charge ATSDR the same amount for indirect costs 
since fiscal year 2004. Without an appropriate indirect cost 
methodology using current cost information and assumptions and 
adequate documentation as called for by relevant guidance, the 
indirect costs charged by CDC for providing administrative services to 
ATSDR cannot be substantiated. Furthermore, it cannot be determined 
whether the amounts paid by ATSDR reasonably approximate actual costs, 
as required by statute. 

We believe CDC's plan to develop a new indirect cost methodology is a 
step in the right direction. As CDC moves forward to develop and 
implement its new methodology, it will be crucial that the methodology 
be periodically evaluated because operations, funding levels, and 
requirements change over time. 

[End of section] 

Recommendations for Executive Action: 

Because of the importance of having an appropriate methodology in 
place to provide a reasonable basis for the indirect costs charged and 
to assist the Congress and agency officials in making decisions about 
allocating federal resources, we recommend that the Director of CDC: 

* continue efforts to develop and implement an appropriate methodology 
for identifying and allocating actual costs, including direct and 
indirect costs to ATSDR, that is in compliance with federal-statutes 
and relevant guidance; 

* document its cost methodology and its process for determining the 
amount charged to ATSDR; and; 

* reevaluate its indirect cost methodology on a regular basis to ensure
that it is adequately identifying and allocating current indirect 
costs. 

[End of section] 

Agency Comments and Our Evaluation: 

We provided a draft of this product to CDC and ATSDR for review and 
comment. 

On April 7, 2010, CDC's Acting Director Executive Secretariat provided 
us with comments on the draft product. 

In their comments, CDC and ATSDR agreed with our recommendations
and provided technical comments that we incorporated as appropriate. 

[End of section] 

GAO Contact and Staff Acknowledgments: 

GAO Contact: 

Kay Daly, (202) 512-9095 or dalykl@gao.gov. 

Staff Acknowledgments: 

In addition to the contact named above, staff members who made key 
contributions to this report include Sabrina Springfield, Assistant 
Director; Jehan Abdel-Gawad; F. Abe Dymond; Jean Mathew; Done!! Ries; 
Ivy Wu; and J. Mark Yoder. 

[End of section] 

[End of Enclosure] 

Footnotes: 

[1] Economy Act, 31 U.S.C. §§ 1535-1536; Chief Financial Officers Act 
of 1990, Pub. L. No. 101-576, 104 Stat. 2838 (Nov. 15, 1990); Federal 
Financial Management Improvement Act of 1996, Pub. L. No. 104-208, 
div. A., § 101(f), title VIII, 110 Stat. 3009, 3009-389 (Sept. 30, 
1996); Federal Acquisition Regulation, subpart 17.5; Federal 
Accounting Standards Advisory Board, Statement of Federal Financial 
Accounting Standards No. 4: Managerial Cost Accounting Concepts and 
Standards for the Federal Government (July 31, 1995); GAO, Managerial 
Cost Accounting Practices: Implementation and Use Vary Widely across 
10 Federal Agencies, [hyperlink, 
http://www.gao.gov/products/GAO-07-679] (Washington, D.C.: July 20, 
2007); and Association of Government Accountants, Managerial Cost 
Accounting in the Federal Government: Providing Useful Information for 
Decision Making, Report No. 22 (September 2009). 

[2] We did not validate CDC's fiscal year 2002 methodology or the 
data, which were last updated in fiscal year 2004, because according 
to CDC officials, the documentation was destroyed in accordance with 
the agency's record retention policies. 

[3] Others include programs that are not funded by CDC's direct 
appropriation, such as Vaccines for Children (VFC) and the President's 
Emergency Plan for AIDS Relief (PEPFAR). VFC is a federally funded 
program that provides vaccines at no cost to children who might not 
otherwise be vaccinated because of an inability to pay. CDC buys 
vaccines at a discount and distributes them to grantees. PEPFAR is a 
federally funded program administered by the Department of State and 
its mission is to prevent and treat HIV/AIDS in other nations. 

[4] Indirect costs are costs that are not specifically identifiable 
with any output and may include costs for general administration, 
research and technical support, and operations and maintenance for 
buildings and equipment. 

[5] House of Representatives Explanatory Statement, 155 Cong. Rec. 
H2113 (daily ed., Feb. 23, 2009), accompanying the Omnibus 
Appropriations Act, 2009 (Pub. L. No. 111-8, 123 Stat. 524) (2009). 

[6] House Report 111-180, Department of the Interior, Environment, and 
Related Agencies Appropriation Bill 2010 (June 23, 2009). 

[7] Economy Act, 31 U.S.C. §§ 1535-1536; Chief Financial Officers Act 
of 1990, Pub. L. No. 101-576, 104 Stat. 2838 (Nov. 15, 1990); Federal 
Financial Management Improvement Act of 1996, Pub. L. No. 104-208, 
div. A., § 101(f), title VIII, 110 Stat. 3009, 3009-389 (Sept. 30, 
1996); Federal Acquisition Regulation, subpart 17.5; Federal 
Accounting Standards Advisory Board, Statement of Federal Financial 
Accounting Standards No. 4: Managerial Cost Accounting Concepts and 
Standards for the Federal Government (July 31, 1995); GAO, Managerial 
Cost Accounting Practices: Implementation and Use Vary Widely across 
10 Federal Agencies, [hyperlink, 
http://www.gao.gov/products/GAO-07-679] (Washington, D.C.: July 20, 
2007); and Association of Government Accountants, Managerial Cost 
Accounting in the Federal Government: Providing Useful Information for 
Decision Making, Report No. 22 (September 2009). 

[8] According to CDC officials, the documents had been destroyed in 
accordance with the agency's record retention policies. 

[9] Department of Health and Human Services, Office of the Inspector 
General, Identification and Allocation of Indirect Costs at the 
Centers for Disease Control and Prevention, A-04-02-08001 (Washington, 
D.C.: Dec. 31, 2003) and Department of Health and Human Services, 
Report of Independent Auditors contained within the Fiscal Year 2008 
Agency Financial Report (Nov. 13, 2008) and Fiscal Year 2009 Agency 
Financial Report (Nov. 10, 2009). 

[10] For a discussion of the reimbursement requirements under the 
Economy Act, see GAO, Principles of Federal Appropriations Law, 3rd 
ed. [hyperlink, http://www.gao.gov/products/GAO-08-978SP] (Washington, 
D.C.: September 2008), vol. 3, ch.12.B.1. 

[11] Federal Accounting Standards Advisory Board, Statement of Federal 
Financial Accounting Standards No. 4: Managerial Cost Accounting 
Concepts and Standards for the Federal Government (July 31, 1995); 
GAO, Managerial Cost Accounting Practices: Implementation and Use Vary 
Widely across 10 Federal Agencies, [hyperlink, 
http://www.gao.gov/products/GAO-07-679] (Washington, D.C.: July 20, 
2007); and Association of Government Accountants, Managerial Cost 
Accounting in the Federal Government: Providing Useful Information for 
Decision Making, Report No. 22 (September 2009). 

[12] A lack of a methodology to determine the proper indirect costs 
could also affect other entities that are charged indirect costs by 
CDC. 

[End of section] 

GAO's Mission: 

The Government Accountability Office, the audit, evaluation and 
investigative arm of Congress, exists to support Congress in meeting 
its constitutional responsibilities and to help improve the performance 
and accountability of the federal government for the American people. 
GAO examines the use of public funds; evaluates federal programs and 
policies; and provides analyses, recommendations, and other assistance 
to help Congress make informed oversight, policy, and funding 
decisions. GAO's commitment to good government is reflected in its core 
values of accountability, integrity, and reliability. 

Obtaining Copies of GAO Reports and Testimony: 

The fastest and easiest way to obtain copies of GAO documents at no 
cost is through GAO's Web site [hyperlink, http://www.gao.gov]. Each 
weekday, GAO posts newly released reports, testimony, and 
correspondence on its Web site. To have GAO e-mail you a list of newly 
posted products every afternoon, go to [hyperlink, http://www.gao.gov] 
and select "E-mail Updates." 

Order by Phone: 

The price of each GAO publication reflects GAO’s actual cost of
production and distribution and depends on the number of pages in the
publication and whether the publication is printed in color or black and
white. Pricing and ordering information is posted on GAO’s Web site, 
[hyperlink, http://www.gao.gov/ordering.htm]. 

Place orders by calling (202) 512-6000, toll free (866) 801-7077, or
TDD (202) 512-2537. 

Orders may be paid for using American Express, Discover Card,
MasterCard, Visa, check, or money order. Call for additional 
information. 

To Report Fraud, Waste, and Abuse in Federal Programs: 

Contact: 

Web site: [hyperlink, http://www.gao.gov/fraudnet/fraudnet.htm]: 
E-mail: fraudnet@gao.gov: 
Automated answering system: (800) 424-5454 or (202) 512-7470: 

Congressional Relations: 

Ralph Dawn, Managing Director, dawnr@gao.gov: 
(202) 512-4400: 
U.S. Government Accountability Office: 
441 G Street NW, Room 7125: 
Washington, D.C. 20548: 

Public Affairs: 

Chuck Young, Managing Director, youngc1@gao.gov: 
(202) 512-4800: 
U.S. Government Accountability Office: 
441 G Street NW, Room 7149: 
Washington, D.C. 20548: